News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Big Bets On Jazz Pharmaceuticals plc (JAZZ) Being The Top Takeover Contender Of 2014



1/3/2014 11:17:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Jazz Pharmaceuticals Plc (JAZZ) just got more alluring as a takeover target after adding to its suite of medicines for rare diseases.

With drugmakers on the prowl for targets in Ireland because of the country’s lower corporate tax rate, investors have been speculating that Dublin-based Jazz may be among the next companies to draw bids. Jazz’s enviable tax base is only part of the appeal as the $7.3 billion company bolsters its product lineup with the $1 billion purchase of rare-disease drug developer Gentium SpA. (GENT)

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES